• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Cannabis Market
    Cannabis News
    Cannabis Stocks
    • Cannabis Market
    • Cannabis News
    • Cannabis Stocks
    cannabis investing

    Aurora Cannabis Drops Amid New Revenue Expectations

    Bryan Mc Govern
    Jan. 08, 2019 04:30PM PST
    Cannabis Investing News
    NYSE:ACB

    Aurora Cannabis saw its share value in Toronto and New York sharply decline on a new revenue projection for its second fiscal quarter.

    Shares of Canadian licensed producer Aurora Cannabis (NYSE:ACB,TSX:ACB) dropped on Tuesday (January 8) following the company’s projections for its fiscal Q2.

    The Canadian firm offered investors a closer look into its unaudited results and confirmed it anticipates revenues between C$50 million and C$55 million for the quarter.

    In its previous fiscal quarter which ended September 30, Aurora brought in C$29.7 million in revenue.

    The actual results for the company will be made public February 11.

    Aurora credited the growth due to the opening of the adult-use cannabis market in Canada, its presence in the medical market and an emerging international play through shipments of medical cannabis products.

    Terry Booth, CEO of Aurora, said the company expects to see a strong demand from the recreational market.

    “Aurora expects its production available for sale will be approximately 25,000 [kilograms] equivalent of cannabis in the Company’s Q4 2019, the period ending June 30, 2019,” the company said.

    Management team for Aurora now believes the producer will be able to reach sustained positive earnings before income, taxes and amortization starting in its fiscal Q4 2019.

    Like many fellow producers, Aurora expects the Canadian market to expand in 2019 thanks to the introduction of edibles and other infused cannabis products into the Cannabis Act.

    This change will allow the sale of vape pens, infused drinks and other popular cannabis edible items.

    Despite the outlook from the company, stock of Aurora declined in value nearly five percent on Tuesday in Toronto. In New York, the company suffered a similar drop and had seen no change during after hours trading.

    Aurora finished the day with a price of C$6.68 in Toronto and US$5.03 in New York.

    Currently, Aurora’s Canadian shares hold a 13.33 average percent upside based on four analyst one-year price targets, according to analyst research aggregator site TipRanks.

    Don’t forget to follow us @INN_Cannabis for real-time news updates!

    Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

    cannabis investingnyse:acbcanadatsx:acb
    The Conversation (0)

    Go Deeper

    AI Powered

    Aurora Cannabis Acquires MedReleaf Australia

    Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

    Latest News

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Cannabis Investing News Stocks

    extractX

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×